Filter
1289
Text search:
clinical
specimens
Featured
207
346
Language
Document type
652
311
132
90
34
31
21
11
3
2
1
1
Countries / Regions
86
44
37
37
32
31
30
28
27
27
21
19
18
18
17
17
17
15
14
13
12
12
12
11
11
10
9
9
8
8
8
8
7
7
6
6
5
5
5
5
5
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
497
171
63
37
35
30
20
Toolboxes
193
168
90
82
68
68
56
41
25
21
19
18
17
14
13
13
12
9
6
3
2
2
1
Up-to-date Literature review current through: Jan 2015. | This topic last updated: Jan 29, 2015.
Clinical Infectious Diseases 2010; 50:291–322
Accessed: 29.09.2019
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is co
...
Updated July 3, 2020
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
Update, 23 de junio de 2022
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos
...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and h
...
